Get started
Accelerate Diagnostics, Inc.Accelerate Diagnostics, Inc.Accelerate Diagnostics, Inc.

Accelerate Diagnostics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

AXDX chart


Full chart

AXDX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪45.83 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.72 USD
Net income (FY)
‪−61.62 M‬ USD
Revenue (FY)
‪12.06 M‬ USD
Shares float
‪14.66 M‬
Beta (1Y)
−0.12

Employees


Employees (FY)
134
Change (1Y)
−45 −25.14%
Revenue / Employee (1Y)
‪89.99 K‬ USD
Net income / Employee (1Y)
‪−459.84 K‬ USD

About Accelerate Diagnostics, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Jack Phillips
Website
acceleratediagnostics.com
Headquarters
Tucson
Founded
1982
FIGI
BBG000CDVK08
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

AXDX news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

AXDX highest yielding bonds


AXDX5604377
Accelerate Diagnostics, Inc. 5.0% 15-DEC-2026
Yield to maturity
86.64%
Maturity date
Dec 15, 2026

Explore more bonds 

Frequently Asked Questions


The current price of AXDX is 1.96 USD — it has increased by 4.37% in the past 24 hours. Watch Accelerate Diagnostics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Accelerate Diagnostics, Inc. stocks are traded under the ticker AXDX.
AXDX stock has fallen by −1.04% compared to the previous week, the month change is a 1.06% rise, over the last year Accelerate Diagnostics, Inc. has showed a −64.81% decrease.
AXDX reached its all-time high on Jun 27, 2014 with the price of 318.56 USD, and its all-time low was 0.73 USD and was reached on Apr 18, 2024. View more price dynamics on AXDX chart.
See other stocks reaching their highest and lowest prices.
AXDX stock is 5.34% volatile and has beta coefficient of −0.12. Track Accelerate Diagnostics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Accelerate Diagnostics, Inc. there?
Today Accelerate Diagnostics, Inc. has the market capitalization of ‪47.83 M‬, it has increased by 3.50% over the last week.
Yes, you can track Accelerate Diagnostics, Inc. financials in yearly and quarterly reports right on TradingView.
Accelerate Diagnostics, Inc. is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
AXDX earnings for the last quarter are −0.54 USD per share, whereas the estimation was −0.47 USD resulting in a −15.35% surprise. The estimated earnings for the next quarter are −0.50 USD per share. See more details about Accelerate Diagnostics, Inc. earnings.
Accelerate Diagnostics, Inc. revenue for the last quarter amounts to ‪2.98 M‬ USD, despite the estimated figure of ‪3.02 M‬ USD. In the next quarter, revenue is expected to reach ‪3.02 M‬ USD.
AXDX net income for the last quarter is ‪−14.64 M‬ USD, while the quarter before that showed ‪−11.59 M‬ USD of net income which accounts for −26.33% change. Track more Accelerate Diagnostics, Inc. financial stats to get the full picture.
No, AXDX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 13, 2024, the company has 134.00 employees. See our rating of the largest employees — is Accelerate Diagnostics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Accelerate Diagnostics, Inc. EBITDA is ‪−34.68 M‬ USD, and current EBITDA margin is −421.05%. See more stats in Accelerate Diagnostics, Inc. financial statements.
Like other stocks, AXDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Accelerate Diagnostics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Accelerate Diagnostics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Accelerate Diagnostics, Inc. stock shows the sell signal. See more of Accelerate Diagnostics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.